Skip to main content

Advertisement

Log in

Risk Profile of Hepatocellular Carcinoma Reveals Dichotomy among US Veterans

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Background

Hepatocellular carcinoma (HCC) is traditionally associated with chronic liver injury resulting from hepatitis B virus (HBV) and hepatitis C virus (HCV) infection or excessive consumption of alcohol. In addition, recent evidence links HCC to diabetes.

Aims

Since these risk factors are prevalent among US veterans, we analyzedcontribution of various etiologies toHCC incidence in this population.

Methods

Clinicopathological correlates of 150 male US veterans diagnosed with HCC between 2001 and 2010 were analyzed and compared to frequency-matched (2:1) non-cancer controls in a single center.

Results

HCC was associated with cirrhosis (odds ratio [OR], 250.84; 95 % confidence interval [CI], 86.92–723.88; p < 0.0001), chronic hepatitis B (OR, 34.30 95 % CI, 1.97–598.47; p = 0.015), chronic hepatitis C (OR, 6.84; 95 % CI, 3.89–12.04; p < 0.0001), alcohol use (OR, 6.76; 95 % CI, 4.35–10.52; p < 0.0001), and smoking (OR, 1.83; 95 % CI, 1.23–2.89; p = 0.009), but surprisingly not with diabetes. Only in a subgroup of HCC patients with no “traditional” risk factors did diabetes become a strong independent predictor of HCC when compared to HCC patients with at least one such risk factor (OR, 10.69; 95 % CI, 1.88–60.63, p = 0.007). This subgroup was further distinguished by older age, increased prevalence of hypertension, nonsmoking, and a trend to develop noncirrhotic HCC.

Conclusions

While HCC in US veterans is overwhelmingly linked to cirrhosis due to “traditional” risk factors, it also occurs with a separate clinical profile characterized by diabetes and no evidence of cirrhosis, suggesting distinct mechanisms of hepatocarcinogenesis and needs for surveillance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. El-Serag HB. Current concepts: hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.

    Article  PubMed  CAS  Google Scholar 

  2. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191–211. v.

    Article  PubMed  Google Scholar 

  3. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.

    Article  PubMed  CAS  Google Scholar 

  4. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485–91.

    Article  PubMed  Google Scholar 

  5. Charlton M. Cirrhosis and liver failure in nonalcoholic fatty liver disease: molehill or mountain? Hepatology. 2008;47:1431–3.

    Article  PubMed  Google Scholar 

  6. Welsch C, Jesudian A, Zeuzem S, Jacobson I. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives. Gut. 2012;61 Suppl 1:i36–46.

    Article  PubMed  CAS  Google Scholar 

  7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348:1625–38.

    Article  PubMed  Google Scholar 

  8. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002;3:565–74.

    Article  PubMed  Google Scholar 

  9. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97:1005–8.

    PubMed  CAS  Google Scholar 

  10. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005;54:533–9.

    Article  PubMed  CAS  Google Scholar 

  11. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126:460–8.

    Article  PubMed  Google Scholar 

  12. Wang CS, Yao WJ, Chang TT, Wang ST, Chou P. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev. 2009;18:2054–60.

    Article  PubMed  CAS  Google Scholar 

  13. Lai S-W, Chen P-C, Liao K-F, Muo C-H, Lin C-C, Sung F-C. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol. 2011;107:46–52.

    Article  PubMed  Google Scholar 

  14. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002;36:1206–13.

    Article  PubMed  CAS  Google Scholar 

  15. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 2008;47:1856–62.

    Article  PubMed  Google Scholar 

  16. Yuan JM, Govindarajan S, Arakawa K, Yu MC. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in Blacks andWhites in the US. Cancer. 2004;101:1009–17.

    Article  PubMed  Google Scholar 

  17. Austin GE, Jensen B, Leete J, De L'Aune W, Bhatnagar J, Racine M, et al. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans. Am J Med Sci. 2000;319:353–9.

    Article  PubMed  CAS  Google Scholar 

  18. Briggs ME, Baker C, Hall R, Gaziano JM, Gagnon D, Bzowej N, et al. Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology. 2001;34:1200–5.

    Article  PubMed  CAS  Google Scholar 

  19. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol. 2000;95:740–7.

    Article  PubMed  CAS  Google Scholar 

  20. Dominitz JA, Boyko EJ, Koepsell TD, Heagerty PJ, Maynard C, Sporleder JL, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005;41:88–96.

    Article  PubMed  Google Scholar 

  21. Kupersmith J, Francis J, Kerr E, Krein S, Pogach L, Kolodner RM, et al. Advancing evidence-based care for diabetes: lessons from the Veterans Health Administration. Health Aff (Millwood). 2007;26:w156–68.

    Article  Google Scholar 

  22. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4:369–80.

    Article  PubMed  Google Scholar 

  23. Wang P, Kang D, Cao W, Wang Y, Liu Z. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2012;28:109–22.

    Article  PubMed  Google Scholar 

  24. Sherman M. Hepatocellular carcinoma: screening and staging. Clin Liver Dis. 2011;15:323–34. vii-x.

    Article  PubMed  Google Scholar 

  25. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.

    Article  PubMed  Google Scholar 

  26. Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology. 2009;49:851–9.

    Article  PubMed  Google Scholar 

  27. Brancatelli G, Federle MP, Grazioli L, Carr BI. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 US residents. Radiology. 2002;222:89–94.

    Article  PubMed  Google Scholar 

  28. Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011;154:85–93.

    Article  PubMed  Google Scholar 

  29. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in nonalcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56:1384–91.

    Article  PubMed  Google Scholar 

  30. Torres DM, Harrison SA. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Sem Liver Dis. 2012;32:30–8.

    Article  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to György Baffy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karagozian, R., Baker, E., Houranieh, A. et al. Risk Profile of Hepatocellular Carcinoma Reveals Dichotomy among US Veterans. J Gastrointest Canc 44, 318–324 (2013). https://doi.org/10.1007/s12029-013-9499-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-013-9499-1

Keywords

Navigation